期刊文献+

口腔癌术区植入缓释氟脲嘧啶的临床研究 被引量:3

Treatment of oral squamous carcinoma by surgery combined with sustained release fluorouracil interstitial chemotherapy
原文传递
导出
摘要 目的:探讨外科手术+全身化疗结合局部植入缓释5-氟脲嘧啶间质化疗药物治疗口腔鳞癌(OSCC)的疗效及安全性。方法:实验组(间质化疗组):33例实施OSCC根治手术及全身静脉化疗,术中植入中人氟安缓释氟尿嘧啶间质化疗药,平均用药剂量为200~400mg;对照组(静脉化疗组)30例OSCC手术结合全身静脉化疗。两组均随访36个月,比较其术后复发率、死亡率以及毒副反应。SPSS统计软件进行统计学分析。结果:随访观察的患者中,实验组术后12、24个月的复发率(6.06%,15.2%)、术后12、24、36个月的死亡率(6.06%,12.1%,24.2%)优于对照组(P<0.05),且其毒副反应与对照组无显著性差异(P>0.05)。结论:手术切除+全身化疗结合局部术区植入缓释氟尿嘧啶间质化疗药物,可以提高肿瘤局部化疗药物的浓度,延长作用时间,在不增加毒副反应的同时提高疗效及生存质量。 Objective:To investigate the therapeutic effect and safety of additional interstitial chemotherapy by biodegradable polymers coated 5-FU after surgery in combination with systemic chemotherapy in oral squamous carcinoma. Method:The patients diagnosed with advanced squamous carcinoma were randomly divided into two groups:the control group and the group with interstitial chemotherapy. 30 patients in the control group were treated by surgery and venous chemotherapy. In the interstitial chemotherapy group,in addition to the same treatment as the control,5-fluorouracil sustained release capsule was additionally planted in tumor bed at a dose range from 200 to 400mg.The patients were followed up for 36 months. The data were processed by SPSS statistical software. Result:After additional treatment with interstitial chemotherapy,the 12-month recurrence rate and 24-month recurrence rate were 6.06 % and 15.2 %. And the 6,24,36 month-mortality rate in the interstitial chemotherapy group were 6.06 %,12.1 %,24.2 %. They were significantly lower than the control group (recurrence rate 13.3 %,23.3 %;and mortality 10 %,20 %,36.7 % respectively)(P〈0.05). In addition, there is no more serious syndrome in the additional interstitial chemotherapy group,when compared with the control. Conclusion:Oral squamous carcinoma with additional interstitial chemotherapy by Fluorouracil sustained release would prolong the survival without significant side-effects,which might act through increase local drug concentration and extend action time.
出处 《临床口腔医学杂志》 2010年第8期480-482,共3页 Journal of Clinical Stomatology
基金 国家自然科学基金资助(30900860)
关键词 口腔鳞癌 间质化疗 缓释 疗效 oral squamous carcinoma interstitial chemotherapy sustained release therapeutic effect
  • 相关文献

参考文献8

  • 1Vartanian JG,Kowalski LP.Acceptance of major surgical procedures and quality of life among long-term survivors of advanced head and neck cancer[J].Obstet Gynecol Surv,2009,64(5):321-334.
  • 2孙黎波,郑光勇.口腔鳞癌诱导化疗的临床研究进展[J].口腔颌面外科杂志,2009,19(3):224-227. 被引量:7
  • 3Schiefke F,Hildebrandt G,Pohlmann S,et al.Combination of surgical resection and HDR-brachytherapy in patients with recurrent or advanced head and neck carcinomas[J].J Craniomaxillofac Surg,2008,36(5):285-292.
  • 4万圣云,刘弋,王瑞祥,王光升.直肠粘膜下植入5-FU缓释剂在直肠癌化疗中的应用[J].中国实用外科杂志,2002,22(10):613-615. 被引量:25
  • 5Bhattacharya A,Tóth K,Sen A,et al.Inhibition of colon cancer growth by methylselenocysteine-induced angiogenic chemomodulation is influenced by histologic characteristics of the tumor[J].Clin Colorectal Cancer,2009,8(3):155-162.
  • 6刘华顶,王世亮,武四化,俞敏,吴静.术中植入缓释氟尿嘧啶治疗大肠癌临床研究[J].腹部外科,2005,18(3):175-176. 被引量:46
  • 7Manabe T,Okino H,Maeyama R,et al.Novel strategic therapeutic approaches for prevention of local recurrence of pancreatic cancer after resection:transtissue,sustained local drug-delivery systems[J].J Control Release,2004,100(3):317-330.
  • 8吴一龙.2005年临床肿瘤学重大进展[J].循证医学,2006,6(2):65-66. 被引量:2

二级参考文献33

  • 1储成顶,成微,王世亮,刘飞,俞敏,鲍玉婷.缓释植入剂局部给药治疗系统的药动学模型[J].中国新药杂志,2004,13(7):613-616. 被引量:23
  • 2万德森,李国材,占友庆,陈敏山.应用氟尿嘧啶肠腔化疗辅助结、直肠癌根治术的远期效果[J].临床外科杂志,1994,2(2):71-73. 被引量:17
  • 3马列,王一春.氟尿嘧啶栓用于直肠癌术前辅助化疗的研究[J].中国药学杂志,1994,29(7):433-435. 被引量:5
  • 4屠规益.诱导化疗在头颈鳞癌综合治疗中的作用[J].中国口腔颌面外科杂志,2006,4(3):162-165. 被引量:16
  • 5骆成玉 李世拥 等.大肠癌淋巴细胞微转移的研究[J].中华外科杂志,2000,38(2):142-142.
  • 6单礼成 董河生 等.直肠癌术前5-FU经静脉辅助化疗后癌细胞形态学和超微结构的改变[J].中华实验外科杂志,1990,7(4):193-193.
  • 7Barone C, Grillo R, Dongiovanni D, et al. Induction chemotherapy followed by concurrent chemoradiotherapy in advanced head and neck squamous cell carcinoma [J]. Anticancer Res,2008,28(2B): 1285-1291.
  • 8Eckardt A, Rades D, Rudat V, et ah Prospective phase Ⅱ study of neoadjuvant radiochemotherapy in advanced operable carcinoma of the mouth cavity. 3-year outcome[J]. Mund Kiefer Gesichtschir,2002, 6(2):117-121.
  • 9Nakazawa M, Ohnishi T, Ohmae M, et al. Phase Ⅱ study of a novel oral formation of 5-fluorouracil in combination with low-dose cisplatin as preoperative chemotherapy of oral squamous cell carcinoma[J]. Int J Clin Pharmacol Res, 2005,25(3):115-122.
  • 10Giralt JL, Gonzalez J, del Campo JM, et al. Preoperative induction chemotherapy followed by concurrent chemoradiotherapy in advanced carcinoma of the oral cavity and oropharynx[J]. Cancer, 2000,89(5) : 939-945.

共引文献74

同被引文献33

引证文献3

二级引证文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部